Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect and Safety of Recombinant Human Interferon α-2b Spray on Herpangina in Pediatric Patients

NCT03266601 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT03266601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03266601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect and Safety of Recombinant Human Interferon α-2b Spray on Herpangina in Pediatric Patients
Lead sponsor
Children's Hospital of Fudan University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2016
Completion date
December 31, 2018
Enrollment
668 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpangina